Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:7261980.
doi: 10.1155/2017/7261980. Epub 2017 Apr 9.

Understanding the Role of Chemokines and Cytokines in Experimental Models of Herpes Simplex Keratitis

Affiliations
Review

Understanding the Role of Chemokines and Cytokines in Experimental Models of Herpes Simplex Keratitis

Tayaba N Azher et al. J Immunol Res. 2017.

Abstract

Herpes simplex keratitis is a disease of the cornea caused by HSV-1. It is a leading cause of corneal blindness in the world. Underlying molecular mechanism is still unknown, but experimental models have helped give a better understanding of the underlying molecular pathology. Cytokines and chemokines are small proteins released by cells that play an important proinflammatory or anti-inflammatory role in modulating the disease process. Cytokines such as IL-17, IL-6, IL-1α, and IFN-γ and chemokines such as MIP-2, MCP-1, MIP-1α, and MIP-1β have proinflammatory role in the destruction caused by HSV including neutrophil infiltration and corneal inflammation, and other chemokines and cytokines such as IL-10 and CCL3 can have a protective role. Most of the damage results from neutrophil infiltration and neovascularization. While many more studies are needed to better understand the role of these molecules in both experimental models and human corneas, current studies indicate that these molecules hold potential to be targets of future therapy.

PubMed Disclaimer

References

    1. Darougar S., Wishart M. S., Viswalingam N. D. Epidemiological and clinical features of primary herpes simplex virus ocular infection. British Journal of Opthalmology. 1985;69(1):2–6. - PMC - PubMed
    1. Liesegang T. J., Melton L. J., Daly P. J. Ilstrup D. M. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Archives of Ophthalmology. 1989;107(8):1155–1159. doi: 10.1001/archopht.1989.01070020221029. - DOI - PubMed
    1. Tang Q., Chen W., Hendricks R. L. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. The Journal of Immunology. 1997;158(3):1275–1283. - PubMed
    1. Tsatsos M., MacGregor C., Athanasiadis I., Moschos M. M., Hossain P., Anderson D. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clinical and Experimental Ophthalmology. 2016;44(9):824–837. doi: 10.1111/ceo.12835. - DOI - PubMed
    1. Gaddipati S., Estrada K., Rao P., Jerome A. D., Suvas S. IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic Stromal Keratitis. The Journal of Immunology. 2015;194(1):273–282. doi: 10.4049/jimmunol.1401285. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources